NEPTUNE PHARMA AS

5440 MOSTERHAMN

Finances

Share Ownership

Return on Equity

−2,21 %

Current Ratio

0,7

Debt-to-Equity Ratio

−1,1

Key figures (NOK)	2022	2021	2020	2019
Revenue	451 000	438 000	27 000	321 000
Net Income	19 000	−624 000	−105 000	−159 000
Total Assets	1 384 000	1 325 000	695 000	641 000
Total Equity	−858 000	−877 000	−253 000	−149 000

Income (NOK)	2022	2021	2020	2019
Revenue	451 000	438 000	27 000	321 000
Expenditure	432 000	1 062 000	131 000	480 000
Operating Profit	19 000	−624 000	−105 000	−159 000
Financial Income	0	0	0	0
Financial Costs	0	0	0	0
Financial Balance	0	0	0	0
Earnings Before Tax	19 000	−624 000	−105 000	−159 000
Tax	0	0	0	0
Net Income	19 000	−624 000	−105 000	−159 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	479 000	479 000	355 000	355 000
Total Current Assets	905 000	846 000	339 000	286 000
Total Assets	1 384 000	1 325 000	695 000	641 000
Total Retained Equity	−888 000	−907 000	−283 000	−179 000
Total Equity	−858 000	−877 000	−253 000	−149 000
Total Long-Term Debt	941 000	901 000	0	0
Total Current Debt	1 302 000	1 302 000	948 000	790 000
Total Equity and Debt	1 384 000	1 325 000	695 000	641 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	451 000	438 000	27 000	321 000
Other Income	0	0	0	0
Revenue	451 000	438 000	27 000	321 000
Cost of Goods Sold	352 000	811 000	59 000	143 000
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	432 000	1 062 000	131 000	480 000
Operating Profit	19 000	−624 000	−105 000	−159 000
Financial Income	0	0	0	0
Financial Costs	0	0	0	0
Financial Balance	0	0	0	0
Dividends	0	0	0	0
Net Income	19 000	−624 000	−105 000	−159 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	479 000	479 000	355 000	355 000
Total Fixed Assets	479 000	479 000	355 000	355 000
Stock	754 000	754 000	220 000	276 000
Total Investments	0	0	0	0
Cash, Bank	62 000	4 000	31 000	0
Total Current Assets	905 000	846 000	339 000	286 000
Total Assets	1 384 000	1 325 000	695 000	641 000
Total Equity	−858 000	−877 000	−253 000	−149 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	941 000	901 000	0	0
Creditors	55 000	55 000	10 000	11 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	1 246 000	1 246 000	938 000	778 000
Total Current Debt	1 302 000	1 302 000	948 000	790 000
Total Equity and Debt	1 384 000	1 325 000	695 000	641 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−2,21 %	71,15 %	41,5 %	106,71 %
Debt-to-Equity Ratio	−1,1	−1,03	−0	−0
Operating Profit Margin	4,21 %	−142,47 %	−388,89 %	−49,53 %
Current Ratio	0,7	0,65	0,36	0,36
Quick Ratio	1,65	1,54	0,47	0,56
Equity Ratio	−0,62	−0,66	−0,36	−0,23
Gross Profit Margin	21,95 %	−85,16 %	−118,52 %	55,45 %